Lv41
790 积分 2023-09-04 加入
Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
2小时前
已完结
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
2小时前
已完结
Mepolizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A scoping review of effectiveness and safety data derived from real-world evidence
3小时前
已完结
Asthma and Pregnancy
21天前
已完结
Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study
21天前
已完结
Airways Remodelling in Asthma: No Doubt, No More?
1个月前
已完结
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study
1个月前
已完结
Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
1个月前
已完结
An evaluation of mepolizumab as an add-on maintenance treatment for severe eosinophilic asthma
1个月前
已完结
COPD exacerbations: targeting IL-33 as a new therapy
1个月前
已完结
皖公网安备34019202002308
